NCT04860856

Brief Summary

The purpose of this study is to evaluate the efficacy of an intra-operative, post-fixation fracture hematoma block compared to saline control on postoperative pain control in patients with acute femoral shaft fractures. Our primary outcome measure is visual analog scale (VAS) pain scores which are recorded at regular intervals.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
88

participants targeted

Target at P50-P75 for phase_4

Timeline
Completed

Started Aug 2019

Longer than P75 for phase_4

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 17, 2019

Completed
1.7 years until next milestone

First Submitted

Initial submission to the registry

April 19, 2021

Completed
8 days until next milestone

First Posted

Study publicly available on registry

April 27, 2021

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 7, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 7, 2023

Completed
Last Updated

February 16, 2023

Status Verified

February 1, 2023

Enrollment Period

3.5 years

First QC Date

April 19, 2021

Last Update Submit

February 14, 2023

Conditions

Keywords

Femoral Intramedullary RodHematoma Block

Outcome Measures

Primary Outcomes (1)

  • Change in postoperative pain at 72 hours

    Postoperative pain will be assessed using a visual analog scale

    Measured at 0, 8, 16, 24, 36, 48, and 72 hours postoperatively

Secondary Outcomes (1)

  • Narcotic usage

    Narcotic usage will be assessed through 72 hours postoperatively

Study Arms (2)

Hematoma block

EXPERIMENTAL

Fracture site injection of 20 mL of 0.5% ropivacaine with an 18-gauge needle (150 mm length).

Drug: 0.5% ropivacaine

Normal saline injection

PLACEBO COMPARATOR

Fracture site injection of 20ml of normal saline.

Drug: Normal Saline

Interventions

The maximal single dose of ropivacaine without vasoconstrictor is 2-3 mg/kg.9 0.5% ropivacaine has 5 mg/mL of ropivacaine. 20 mL of 0.5% ropivacaine has 100 mg of ropivacaine. 100 mg of ropivacaine can be toxic to a patient less than 33-50 kg or 73-110 lb. If a patient weighs less than 110 lb, the ropivacaine dose will be scaled down below 2 mg/kg.

Hematoma block

20ml of normal saline

Normal saline injection

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Trauma patient at the University of Cincinnati Medical Center
  • Skeletally mature patients
  • Have an isolated, closed, acute traumatic femoral shaft fracture to be treated with a closed reduction and reamed intramedullary rod fixation

You may not qualify if:

  • Unable to provide informed consent
  • Member of a vulnerable patient population
  • Have additional injuries
  • Have a history of prior existing narcotic use or chronic pain management issues on presentation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Cincinnati College of Medicine

Cincinnati, Ohio, 45267, United States

Location

Related Publications (9)

  • Alioto RJ, Furia JP, Marquardt JD. Hematoma block for ankle fractures: a safe and efficacious technique for manipulations. J Orthop Trauma. 1995 Apr;9(2):113-6. doi: 10.1097/00005131-199504000-00004.

    PMID: 7776029BACKGROUND
  • Bear DM, Friel NA, Lupo CL, Pitetti R, Ward WT. Hematoma block versus sedation for the reduction of distal radius fractures in children. J Hand Surg Am. 2015 Jan;40(1):57-61. doi: 10.1016/j.jhsa.2014.08.039. Epub 2014 Oct 11.

    PMID: 25306504BACKGROUND
  • Case RD. Haematoma block--a safe method of reducing Colles' fractures. Injury. 1985 Jul;16(7):469-70. doi: 10.1016/0020-1383(85)90168-8.

    PMID: 4030071BACKGROUND
  • Herrera JA, Wall EJ, Foad SL. Hematoma block reduces narcotic pain medication after femoral elastic nailing in children. J Pediatr Orthop. 2004 May-Jun;24(3):254-6. doi: 10.1097/00004694-200405000-00003.

    PMID: 15105718BACKGROUND
  • Gallagher EJ, Liebman M, Bijur PE. Prospective validation of clinically important changes in pain severity measured on a visual analog scale. Ann Emerg Med. 2001 Dec;38(6):633-8. doi: 10.1067/mem.2001.118863.

    PMID: 11719741BACKGROUND
  • Koehler D, Marsh JL, Karam M, Fruehling C, Willey M. Efficacy of Surgical-Site, Multimodal Drug Injection Following Operative Management of Femoral Fractures: A Randomized Controlled Trial. J Bone Joint Surg Am. 2017 Mar 15;99(6):512-519. doi: 10.2106/JBJS.16.00733.

    PMID: 28291185BACKGROUND
  • Johnson PQ, Noffsinger MA. Hematoma block of distal forearm fractures. Is it safe? Orthop Rev. 1991 Nov;20(11):977-9.

    PMID: 1749663BACKGROUND
  • Dimopoulou I, Anagnostou TL, Prassinos NN, Savvas I, Patsikas M. Effect of intrafragmentary bupivacaine (haematoma block) on analgesic requirements in dogs undergoing fracture repair. Vet Anaesth Analg. 2017 Sep;44(5):1189-1197. doi: 10.1016/j.vaa.2017.01.005. Epub 2017 Mar 6.

    PMID: 29100681BACKGROUND
  • Yue RA, Shah NS, Matar RN, Sagi HC. Efficacy of Hematoma Block After Intramedullary Rod Fixation of Femoral Shaft Fractures: A Prospective, Double-Blinded, Randomized Controlled Trial. J Orthop Trauma. 2023 Sep 1;37(9):429-432. doi: 10.1097/BOT.0000000000002623.

MeSH Terms

Conditions

Femoral Fractures

Interventions

RopivacaineSaline Solution

Condition Hierarchy (Ancestors)

Fractures, BoneWounds and InjuriesLeg Injuries

Intervention Hierarchy (Ancestors)

AnilidesAmidesOrganic ChemicalsAniline CompoundsAminesCrystalloid SolutionsIsotonic SolutionsSolutionsPharmaceutical Preparations

Study Officials

  • He C S, MD

    University of Cincinnati

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Masking Details
The patients and the nursing staff who assess postoperative pain will be blinded to the treatment allocation.
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Blinded, randomized control trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 19, 2021

First Posted

April 27, 2021

Study Start

August 17, 2019

Primary Completion

February 7, 2023

Study Completion

February 7, 2023

Last Updated

February 16, 2023

Record last verified: 2023-02

Data Sharing

IPD Sharing
Will not share

Locations